BlackRock increases long stake in Jiangsu Hengrui H-shares to 7.68%
A Hong Kong Exchange filing shows BlackRock increased its long position in Jiangsu Hengrui Pharmaceuticals’ H-shares to 7.68% as of Sept 14.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.